Acceleron Pharma Inc - Company Profile
Powered by 
All the data and insights you need on Acceleron Pharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Acceleron Pharma Inc Strategy Report
- Understand Acceleron Pharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Acceleron Pharma Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2022192411A1 | Application | ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE | September 15, 2022 | |
| WO2022192420A2 | Application | ACTRII PROTEINS AND USES THEREOF | September 15, 2022 | |
| WO2022192404A1 | Application | ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE | September 15, 2022 | |
| EP4054617A1 | Application | BEHANDLUNGEN FÜR SYSTEMISCHE SKLEROSE | A61K38/179; A61P11/00; A61P37/00; C07K14/495; C07K14/71; C07K2319/30 | September 14, 2022 |
| CN104548056B | Grant | 活化素-ACTRIIA拮抗剂和促进癌症患者骨骼生长的用途 | A61K2039/505; A61K38/179; A61K38/1796; A61K38/18; A61K39/39558; A61K45/06; A61P13/12; A61P19/00; A61P19/08; A61P19/10; A61P21/00; A61P35/00; A61P35/04; A61P43/00; A61P5/14; A61P5/18; C07K14/4702; C07K14/71; C07K16/3061; C07K19/00; C07K2317/21; C07K2317/24; C07K2317/31; C07K2317/54; C07K2317/55; C07K2317/622; C07K2319/02; C07K2319/30; H04L2212/00; H04W40/00; H04W8/082; H04W80/04; H04W84/18 | September 09, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer